Commentary / World Feb 27, 2023
A refreshing gamble on Crispr delivery
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
American kids are struggling with mental anxiety and other issues and there are too few trained adults available to help them.
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
Amgen’s obesity drug offers a new twist on proven methods to help people lose unwanted pounds.
Early data bodes well for Pfizer’s RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren’t yet on board.
Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it’s a lot more complicated.